Progranulin and CTRP3 in Metabolic Syndrome
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 127
- 试验地点
- 1
- 主要终点
- Serum concentration of progranulin in the subjects with metabolic syndrome
研究概览
简要总结
Inflammation has been known to be a pivotal pathogenic mechanism of obesity-related disorders such as type 2 diabetes, metabolic syndrome and atherosclerosis. Adipose tissue functions as a major endocrine organ by adipokine mediated modulation of a number of signaling cascades in target tissues, that has pro-inflammatory or anti-inflammatory activities. Progranulin and CTRP3 are recently discovered novel adipokines. Therefore, the investigators tried to clarify the clinical meaning of these two adipokines in the subjects with or without metabolic syndrome
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 20 Years 至 80 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •20<age<80
- •apparently healthy subjects
排除标准
- •a history of CVD
- •stage 2 hypertension
- •malignancy
- •severe renal or hepatic disease
结局指标
主要结局
Serum concentration of progranulin in the subjects with metabolic syndrome
时间窗: 12week
Serum concentration of CTRP3 in the subjects with metabolic syndrome
时间窗: 12week
次要结局
- The relationship of serum progranulin levels with cardiovascular risk factors(12 week)
- The relationship of serum CTRP3 levels with cardiovascular risk factors(12 week)
